The PE Ratio as of December 2024 (TTM) for Manhattan Scientifics, Inc. (MHTX) is -0.07

According to Manhattan Scientifics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.07. This represents a change of -95.36% compared to the average of -1.51 of the last 4 quarters.

Manhattan Scientifics, Inc. (MHTX) Historical PE Ratio (quarterly & annually)

How has MHTX PE Ratio performed in the past?

The mean historical PE Ratio of Manhattan Scientifics, Inc. over the last ten years is -1.09. The current -0.07 PE Ratio has changed 540.33% with respect to the historical average. Over the past ten years (40 quarters), MHTX's PE Ratio was at its highest in in the March 2021 quarter at 44.76. The PE Ratio was at its lowest in in the December 2021 quarter at -65.80.

Manhattan Scientifics, Inc. (MHTX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Manhattan Scientifics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Manhattan Scientifics, Inc. (MHTX) Average PE Ratio

How has MHTX PE Ratio performed in the past?

The current PE Ratio of Manhattan Scientifics, Inc. (MHTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Manhattan Scientifics, Inc. (MHTX) PE Ratio vs. Peers

How is MHTX’s PE Ratio compared to its peers?

Manhattan Scientifics, Inc.’s PE Ratio is greater than VentriPoint Diagnostics Ltd. (-3.09), greater than Cannabix Technologies Inc. (-9.67), greater than Accelerate Diagnostics, Inc. (-0.50), less than Venus Concept Inc. (-0.05), less than Nemaura Medical Inc. (-0.00), greater than Bluejay Diagnostics, Inc. (-4.23), greater than Movano Inc. (-1.54), less than INVO Bioscience, Inc. (0), greater than enVVeno Medical Corporation (-2.13), greater than OpGen, Inc. (-0.37), greater than Biomerica, Inc. (-0.76), less than BIOLASE, Inc. (-0.03), less than Semler Scientific, Inc. (31.56), greater than NanoVibronix, Inc. (-0.49), greater than Asensus Surgical, Inc. (-1.13), less than DexCom, Inc. (46.46), greater than Tandem Diabetes Care, Inc. (-19.13), greater than Pacific Biosciences of California, Inc. (-1.35), greater than Nano-X Imaging Ltd. (-8.35),

Build a custom stock screener for Manhattan Scientifics, Inc. (MHTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Manhattan Scientifics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Manhattan Scientifics, Inc. (MHTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Manhattan Scientifics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.